TrialJAMA ophthalmology2018

Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial.

Ian L McAllister et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.